Weight loss drugs without side effects Top researchers propose new ...
A provocative new study suggests that mechanisms other than GLP-1 could cause weight loss without side effects.
The upcoming drugs CagriSema and retatrutide target multiple gut hormones and could cause twice as much weight loss than current treatments. But experts wonder how much is too much
Key Details About Glp 1 Weight Loss Drugs Get A New Discovery Study
via HealthDay FRIDAY, Sept. 19, 2025 — An effective weight-loss pill to rival injectable drugs like Ozempic and Zepbound might be on the horizon, clinical trial results show. An experimental GLP-1 pill called orforglipron promoted substantial weight loss without the need for weekly injections, according to final clinical trial results published Sept. 16 in The New England Journal of Medicine ...
A new strategy for delivering GLP-1 drugs to patients with obesity or who were overweight resulted in up to an 11 percent reduction in body weight after 36 weeks, according to a randomized phase II clinical trial published in Nature Medicine.
New Formulations of GLP
An average weight loss of 7.9% (roughly 16lbs) at the highest dose was also demonstrated, with indication of further potential loss , as participants did not appear to have reached a weight plateau at the conclusion of the study .
The success of these medicines has spurred development of next-generation GLP-1-based drugs , promising greater weight loss , improved tolerability and additional options for the route and frequency ...
New GLP
A new experimental GLP-1 pill could make it easier for people with type 2 diabetes to access treatments that help control blood sugar and support weight loss .
Introduction In recent years, GLP-1 receptor agonists have emerged as one of the most important breakthroughs in modern metabolic medicine. Originally developed to treat type 2 diabetes, these medications are now widely used for weight loss , cardiovascular risk reduction, and metabolic disease management. Drugs such as Ozempic, Wegovy, and Mounjaro have rapidly gained global attention for ...
Scientists reveal pill that helps shed 20 of body weight
A massive international study has shown that the experimental oral obesity drug orforglipron can help patients shed over 10% of their body weight , with nearly one in five losing 20% or more ...
Orforglipron, a small-molecule, nonpeptide oral glucagon-like peptide-1 ( GLP-1 ) receptor agonist, is being investigated as a treatment for obesity.